Earnings Summary

Pfizer Inc.’s revenue fell -41.34% since last year same period to $14249Mn in the Q4 2023. On a quarterly growth basis, Pfizer Inc. has generated 7.69% jump in its revenue since last 3-months.

Pfizer Inc.’s net profit fell -166.96% since last year same period to $-3344Mn in the Q4 2023. On a quarterly growth basis, Pfizer Inc. has generated -39.68% fall in its net profits since last 3-months.

Pfizer Inc.’s net profit margin fell -214.15% since last year same period to -23.47% in the Q4 2023. On a quarterly growth basis, Pfizer Inc. has generated -29.71% fall in its net profit margins since last 3-months.

Pfizer Inc.’s price-to-earnings ratio after this Q4 2023 earnings stands at 69.89.

Pfizer Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.53 - a 340.91% jump from last quarter’s estimates.

Pfizer Inc.’s earning per share (EPS) estimates for the current year stand at 0.53.

Pfizer Inc.’s earning per share (EPS) fell -91.23% since last year same period to 0.1 in the Q4 2023. This indicates that the Pfizer Inc. has generated -91.23% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Pfizer Inc.’s return on assets (ROA) stands at 0.02.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Pfizer Inc.’s return on equity (ROE) stands at 0.02.

Pfizer Inc. declared 0.82 dividend per share during the earnings announcement for Q4 2023.